Organigram Global (OGI) Change in Intangibles (2020 - 2026)
Organigram Global (OGI) posted quarterly Change in Intangibles of -$16771.7 for Q1 2026, up 44.03% year-on-year from -$11644.3 in Q1 2025, and up 44.03% on a QoQ basis from -$29967.4 in Q1 2025.
Organigram Global (OGI) Change in Intangibles (2020 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Intangibles for 5 consecutive years, with -$16771.7 the latest figure, recorded in Q1 2026.
- Quarterly Change in Intangibles rose 44.03% year-over-year to -$16771.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$299181.8 (down 15.78% YoY) and the FY2021 annual result came in at -$16000.0, changed N/A from the prior year.
- Change in Intangibles rose to -$16771.7 in Q1 2026 per OGI's latest filing, from -$29967.4 in the prior quarter.
- Over the last five years, Change in Intangibles for OGI reached as high as -$6442.6 in Q4 2024 and fell as low as -$29967.4 in Q1 2025.
- A 3-year average of -$17727.3 and a median of -$16771.7 in 2026 frame the typical range for Change in Intangibles.
- The largest YoY upside for Change in Intangibles was 44.03% in 2026 against a maximum downside of 44.03% in 2026.
- Year by year, Change in Intangibles stood at -$6442.6 in 2024, then plunged by 365.14% to -$29967.4 in 2025, then jumped by 44.03% to -$16771.7 in 2026.
- According to Business Quant data, Change in Intangibles over the past three periods registered -$16771.7, -$29967.4, and -$6442.6 for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 119.50 Mn | 152.58 Mn | 28.97 Mn | -16,771.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,771.73 |
| Mar 31, 2026 | -16,771.73 |
| Mar 31, 2025 | -29,967.41 |
| Mar 31, 2025 | -29,967.41 |
| Dec 31, 2024 | -6,442.64 |
| Dec 31, 2024 | -6,442.64 |
| May 31, 2021 | -246,000.00 |
| May 31, 2021 | -246,000.00 |
| Feb 28, 2021 | 24,000.00 |
| Feb 28, 2021 | 24,000.00 |
| Nov 30, 2020 | -24,000.00 |
| Nov 30, 2020 | -24,000.00 |
| May 31, 2020 | -68,649.35 |
| May 31, 2020 | -68,649.35 |
| Feb 29, 2020 | -237,000.00 |
| Feb 29, 2020 | -237,000.00 |